Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device

J Thorac Cardiovasc Surg. 2002 Feb;123(2):384-5. doi: 10.1067/mtc.2002.119328.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Coagulation Disorders / drug therapy*
  • Factor VIIa / therapeutic use*
  • Heart-Assist Devices*
  • Humans
  • Male
  • Recombinant Proteins / therapeutic use*

Substances

  • Recombinant Proteins
  • Factor VIIa